Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri Daldegan-Bueno

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The New Zealand Medical Journal|August 11, 2020
New Zealand's 'Cannabis Legalisation and Regulation Bill': an evidence-based assessment and critique of essential regulatory components towards policy outcomesBenedikt Fischer, Dimitri Daldegan-Bueno
Pain and Therapy|December 31, 2020
Comparison of Crude Population-Level Indicators of Opioid Use and Related Harm in New Zealand and Ontario (Canada)Benedikt Fischer, Dimitri Daldegan-Bueno, Wayne Jones
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 25, 2026
Use of Identity Theories in Smoking Cessation Research: A Scoping ReviewNatalia Maria Simionato, Dimitri Daldegan-Bueno, Rodrigo Ramalho
Substance Use & Misuse|June 22, 2022
Conceptualizing and considering Cannabis-Related "Harm-to-Others": The Role of Cannabis-Related ViolenceDimitri Daldegan-Bueno, Sheila Rubia Lindner, Benedikt Fischer
Substance Abuse Treatment, Prevention, and Policy|January 27, 2021
Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicatorsLucas O Maia, Dimitri Daldegan-Bueno, Benedikt Fischer
Drug and Alcohol Review|May 22, 2020
Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerationsBenedikt Fischer, Dimitri Daldegan-Bueno, Joseph M Boden
Journal of Psychoactive Drugs|December 8, 2020
The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative studyLucas Oliveira Maia, Dimitri Daldegan-Bueno, Luís Fernando Tófoli
Drug and Alcohol Review|November 29, 2022
Cannabis use, risk behaviours and harms in Brazil: A comprehensive review of available data indicatorsDimitri Daldegan-Bueno, Sheila R Lindner, Douglas Kovaleski, et al.
Substance Abuse Treatment, Prevention, and Policy|February 16, 2021
'Resurgent', 'twin' or 'silent' epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North AmericaBenedikt Fischer, Caroline O'Keefe-Markman, Angelica Min-Hye Lee, et al.
The International Journal on Drug Policy|February 19, 2021
Why comparative epidemiological indicators suggest that New Zealand is unlikely to experience a severe opioid epidemicBenedikt Fischer, Caroline O-Keefe-Markman, Dimitri Daldegan-Bueno, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The New Zealand Medical Journal|August 11, 2020
New Zealand's 'Cannabis Legalisation and Regulation Bill': an evidence-based assessment and critique of essential regulatory components towards policy outcomesBenedikt Fischer, Dimitri Daldegan-Bueno
Pain and Therapy|December 31, 2020
Comparison of Crude Population-Level Indicators of Opioid Use and Related Harm in New Zealand and Ontario (Canada)Benedikt Fischer, Dimitri Daldegan-Bueno, Wayne Jones
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 25, 2026
Use of Identity Theories in Smoking Cessation Research: A Scoping ReviewNatalia Maria Simionato, Dimitri Daldegan-Bueno, Rodrigo Ramalho
Substance Use & Misuse|June 22, 2022
Conceptualizing and considering Cannabis-Related "Harm-to-Others": The Role of Cannabis-Related ViolenceDimitri Daldegan-Bueno, Sheila Rubia Lindner, Benedikt Fischer
Substance Abuse Treatment, Prevention, and Policy|January 27, 2021
Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicatorsLucas O Maia, Dimitri Daldegan-Bueno, Benedikt Fischer
Drug and Alcohol Review|May 22, 2020
Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerationsBenedikt Fischer, Dimitri Daldegan-Bueno, Joseph M Boden
Journal of Psychoactive Drugs|December 8, 2020
The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative studyLucas Oliveira Maia, Dimitri Daldegan-Bueno, Luís Fernando Tófoli
Drug and Alcohol Review|November 29, 2022
Cannabis use, risk behaviours and harms in Brazil: A comprehensive review of available data indicatorsDimitri Daldegan-Bueno, Sheila R Lindner, Douglas Kovaleski, et al.
Substance Abuse Treatment, Prevention, and Policy|February 16, 2021
'Resurgent', 'twin' or 'silent' epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North AmericaBenedikt Fischer, Caroline O'Keefe-Markman, Angelica Min-Hye Lee, et al.
The International Journal on Drug Policy|February 19, 2021
Why comparative epidemiological indicators suggest that New Zealand is unlikely to experience a severe opioid epidemicBenedikt Fischer, Caroline O-Keefe-Markman, Dimitri Daldegan-Bueno, et al.
Pageof 4